The US state of Vermont's House of Representatives has given preliminaryapproval to a bill aiming to cut prescription drug prices in the state, say Associated Press reports. The bill would: give healthcare providers more education and training on alternatives to brand-name drugs; establish a formulary; help set up more "federally-qualified health centers," whose patients would qualify for the lowest drug prices charged to participants in federal health plans; and extend the state plan providing drug discounts of 18%-30% to enrollees in the state Medicaid program.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze